CR20110090A - HUMAN CITOMEGALOVIRUS THAT NEUTRALIZES ANTIBODIES AND ITS USE - Google Patents

HUMAN CITOMEGALOVIRUS THAT NEUTRALIZES ANTIBODIES AND ITS USE

Info

Publication number
CR20110090A
CR20110090A CR20110090A CR20110090A CR20110090A CR 20110090 A CR20110090 A CR 20110090A CR 20110090 A CR20110090 A CR 20110090A CR 20110090 A CR20110090 A CR 20110090A CR 20110090 A CR20110090 A CR 20110090A
Authority
CR
Costa Rica
Prior art keywords
antibodies
human
citomegalovirus
neutralizes
neutralizes antibodies
Prior art date
Application number
CR20110090A
Other languages
Spanish (es)
Inventor
Antonio Lanzaveccia
Annalisa Macagno
Original Assignee
Humabs Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Humabs Llc filed Critical Humabs Llc
Priority to CR20110090A priority Critical patent/CR20110090A/en
Publication of CR20110090A publication Critical patent/CR20110090A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención describe anticuerpos de neutralización que son específicos para citomegalovirus humano (hCMV), específicamente los anticuerpos de la invención son específicos para una combinación de proteínas de hCMV UL128, UL130 y UL131A.The invention describes neutralization antibodies that are specific for human cytomegalovirus (hCMV), specifically the antibodies of the invention are specific for a combination of hCMV proteins UL128, UL130 and UL131A.

CR20110090A 2011-02-16 2011-02-16 HUMAN CITOMEGALOVIRUS THAT NEUTRALIZES ANTIBODIES AND ITS USE CR20110090A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR20110090A CR20110090A (en) 2011-02-16 2011-02-16 HUMAN CITOMEGALOVIRUS THAT NEUTRALIZES ANTIBODIES AND ITS USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR20110090A CR20110090A (en) 2011-02-16 2011-02-16 HUMAN CITOMEGALOVIRUS THAT NEUTRALIZES ANTIBODIES AND ITS USE

Publications (1)

Publication Number Publication Date
CR20110090A true CR20110090A (en) 2011-05-16

Family

ID=51359520

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110090A CR20110090A (en) 2011-02-16 2011-02-16 HUMAN CITOMEGALOVIRUS THAT NEUTRALIZES ANTIBODIES AND ITS USE

Country Status (1)

Country Link
CR (1) CR20110090A (en)

Similar Documents

Publication Publication Date Title
IL293362B1 (en) Broad-spectrum neutralizing antibodies against the AIDS virus
ECSP13012786A (en) ANTI-PCSK9 ANTIBODIES AND METHODS OF USE
ECSP13012440A (en) ANTI-FAP ANTIBODIES AND METHODS OF USE
CR20140212A (en) ANTI-HTRA1 ANTIBODIES AND METHODS OF USE
UY34876A (en) ANTI-EGFR ANTIBODIES AND USES OF THE SAME
CR20140382A (en) ANTI-LRP5 ANTIBODIES AND METHODS OF USE
PE20210648A1 (en) ANTI-CD3 ANTIBODIES AND METHODS OF USE
CR20150049A (en) ANTI-CD79B ANTIBODIES AND IMMUNOCATION
CL2016001432A1 (en) New anti-dpep3 antibodies and methods of use
CR20150046A (en) ANTI-CD79B ANTIBODIES AND IMMUNOCATE PLAYERS
CR20150618A (en) ANTITRANSPHERINE RECEIVING ANTIBODIES AND METHODS OF USE
CL2015000582A1 (en) Anti-mcam antibodies and associated methods of use
CL2016000460A1 (en) Gitr antigen binding proteins
MX342240B (en) Anti-fgfr4 antibodies and methods of use.
UY34017A (en) FUSION PROTEINS AND COMBINATION VACCINES
CR20160270A (en) ANTI-TAU ANTIBODIES (pS422) HUMANIZED AND USED METHODS
CR20150247A (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
MX2019007921A (en) Novel ha binding agents.
HUE053545T2 (en) Human immunodeficiency virus neutralizing antibodies and methods for their use
MX2016005631A (en) ANTI-alpha-SYNUCLEIN ANTIBODIES AND METHODS OF USE.
EP2902844A4 (en) LIGHT SOURCE SYSTEM AND RELATED PROJECTION SYSTEM
EP2939070A4 (en) LIGHT SOURCE DEVICE AND PROJECTOR USING THE SAME
UY34603A (en) ANTI-ASIC-1 ANTIBODIES AND USES OF THE SAME
MX354303B (en) Anti-biotin antibodies and methods of use.
CO6920284A2 (en) Reflector, illuminator and use thereof